Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Statin therapy in primary prevention: new insights regarding women and the elderly.

Harrington C, Horne A Jr, Hasan RK, Blumenthal RS.

Am J Cardiol. 2010 Nov 1;106(9):1357-9. doi: 10.1016/j.amjcard.2010.06.067. Epub 2010 Sep 9. No abstract available.

PMID:
21029838
2.

The JUPITER Trial: responding to the critics.

Ridker PM, Glynn RJ.

Am J Cardiol. 2010 Nov 1;106(9):1351-6. doi: 10.1016/j.amjcard.2010.08.025. Epub 2010 Sep 21. No abstract available.

PMID:
21029837
3.

Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein.

Ridker PM, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Khurmi NS, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Trial Study Group.

Am J Cardiol. 2007 Dec 1;100(11):1659-64. Epub 2007 Oct 24.

4.

JUPITER strikes earth.

Fuster V, Bansilal S.

Nat Clin Pract Cardiovasc Med. 2009 Mar;6(3):159. doi: 10.1038/ncpcardio1454. No abstract available. Erratum in: Nat Clin Pract Cardiovasc Med. 2009 May;6(5):326.

PMID:
19234496
5.

The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin).

O'Keefe JH, Carter MD, Lavie CJ, Bell DS.

Postgrad Med. 2009 May;121(3):113-8. doi: 10.3810/pgm.2009.05.2010. Review.

PMID:
19491548
7.

The numbers are in: statins for the primary prevention of cardiovascular disease in women.

Duvernoy CS, Blumenthal R.

Circulation. 2010 Mar 9;121(9):1063-5. doi: 10.1161/CIR.0b013e3181d731c6. Epub 2010 Feb 22. No abstract available.

8.

[Statin cuts cardiovascular risk in half].

Einecke D.

MMW Fortschr Med. 2008 Dec 4;150(49-50):12-3. German. No abstract available.

PMID:
19133364
9.

The editor's roundtable: the JUPITER trial--initial results and clinical implications.

Ridker PM, Friedewald VE, Davidson MH, Willerson JT, Roberts WC.

Am J Cardiol. 2009 May 15;103(10):1417-25. doi: 10.1016/j.amjcard.2009.02.023. No abstract available.

PMID:
19427439
10.

The cost-effectiveness of rosuvastatin therapy JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).

Hlatky M.

J Am Coll Cardiol. 2011 Feb 15;57(7):792-3. doi: 10.1016/j.jacc.2010.09.051. No abstract available.

11.

Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).

Ridker PM, MacFadyen JG, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group.

Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):616-23. doi: 10.1161/CIRCOUTCOMES.109.848473. Epub 2009 Sep 22.

12.

Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?

Couzin J.

Science. 2008 Nov 14;322(5904):1039. doi: 10.1126/science.322.5904.1039. No abstract available.

PMID:
19008423
13.

Expanding the orbit of primary prevention--moving beyond JUPITER.

Hlatky MA.

N Engl J Med. 2008 Nov 20;359(21):2280-2. doi: 10.1056/NEJMe0808320. Epub 2008 Nov 9. No abstract available.

14.

The role of C-reactive protein (CRP) and statin treatment in reducing cardiovascular risk.

Chin J.

S D Med. 2009 Mar;62(3):104-6. No abstract available.

PMID:
19480274
15.

The Jupiter trial: key findings, controversies, and implications.

Nissen SE.

Curr Cardiol Rep. 2009 Mar;11(2):81-2. No abstract available.

PMID:
19236822
16.

Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.

Fonseca FA, Izar MC.

Expert Rev Cardiovasc Ther. 2009 Sep;7(9):1041-56. doi: 10.1586/erc.09.93.

PMID:
19764857
17.

Study stirs debate about statin use in those without high cholesterol.

[No authors listed]

Mayo Clin Womens Healthsource. 2009 Apr;13(4):3. No abstract available.

PMID:
19255535
19.

The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels.

Choudhry NK, Patrick AR, Glynn RJ, Avorn J.

J Am Coll Cardiol. 2011 Feb 15;57(7):784-91. doi: 10.1016/j.jacc.2010.07.059.

20.

[JUPITER study (2). For now no reason to give statins to more people].

Koopmans RP.

Ned Tijdschr Geneeskd. 2009 Feb 7;153(6):218-9. Dutch. No abstract available.

PMID:
19271439
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk